MEDNAX, Inc. (NYSE:MD) went down by -21.17% from its latest closing price when compared to the 1-year high value of $36.81 and move down -75.62%, while MD stocks collected -20.91% of loss with the last five trading sessions. Barron's reported 8 hours ago that Mednax Stock Is Falling Because UnitedHealth Is Ending Contracts

MEDNAX, Inc. (NYSE:MD) Worth an Investment?

MEDNAX, Inc. (NYSE: MD) The 36 Months beta value for MD stocks is at 0.90, while of the analysts out of 0 who provided ratings for MEDNAX, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $26.58 which is $6.29 above current price. MD currently has a short float of 6.68% and public float of 80.94 M with average trading volume of 1.03M shares.

MD Market Performance

MD stocks went down by -20.91% for the week, with the monthly drop of -22.77% and a quarterly performance of -19.75%, while its annual performance rate touched -42.35%. The simple moving average for the period of the last 20 days is -18.79% for MD stocks with the simple moving average of -15.58% for the last 200 days.

Analysts’ Opinion on MEDNAX, Inc. (NYSE:MD)

Many brokerage firms have already submitted their reports for MD stocks, with Citigroup repeating the rating for MD shares by setting it to “Neutral”. The predicted price for MD socks in the upcoming period according to Citigroup is $29 based on the research report published on January 3, 2020.

Stifel, on the other hand, stated in their research note that they expect to see MD stock at the price of $33, previously predicting the value of $25. The rating they have provided for MD stocks is “Buy” according to the report published on December 12, 2019.

BofA/Merrill gave “ Underperform” rating to MD stocks, setting the target price at $33 in the report published on September 6, 2019.

MD Stocks -21.36% Far from 50 Day Moving Average

After a stumble in the market that brought MD to its low price for the period of the last 52 weeks, MEDNAX, Inc. was unable to take a rebound, for now settling with -43.06% of loss for the given period.

The stock volatility was left at 3.88%, however, within the period of a single month, the volatility rate increased by 5.76%, while the shares sank at the distance of -23.89% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -19.10% lower at the present time.

In the course of the last 5 trading sessions, MD went down by -20.91%, which changed the moving average for the period of 200 days to the total of -29.26% of losses for the stock in comparison to the 20-day moving average settled at $25.48. In addition, MEDNAX, Inc. saw -24.58% in overturn over the period of a single year with a tendency to cut further losses.

MD Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at MEDNAX, Inc. (MD), starting from Goldschmidt, MD Pascal J, who sold 5,000 shares at the price of $22.88 back on Nov 01. After this action, Rushing now owns 10,821 shares of MEDNAX, Inc., valued at $114,403 with the latest closing price.

Goldschmidt, MD Pascal J, the Director of MEDNAX, Inc., sold 5,000 shares at the value of $20.81 during a trade that took place back on Sep 03, which means that Goldschmidt, MD Pascal J is holding 15,821 shares at the value of $104,050 based on the most recent closing price.

MD Stock Fundamentals

The current profitability levels are settled at +12.22 for the present operating margin and +24.08 for gross margin. The net margin for MEDNAX, Inc. stands at +7.37. Total capital return value is set at 8.93, while invested capital returns managed to touch 5.38. Equity return holds the value -57.50%, with -26.80% for asset returns.

Based on MEDNAX, Inc. (MD), the company’s capital structure generated 63.94 points for debt to equity in total, while total debt to capital is set at the value of 39.00. Total debt to assets is settled at the value of 33.27 with long-term debt to equity ratio rests at 5.02 and long-term debt to capital is 63.94.

The value for Enterprise to Sales is 1.08 with debt to enterprise value settled at 0.40. The receivables turnover for MEDNAX, Inc. is 6.97 with the total asset turnover at the value of 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.31.